Briefs: Dr. Reddy's Laboratories and Ami Organics
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
New solvent-free micronization technology expanded at the Darmstadt site in Germany
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Subscribe To Our Newsletter & Stay Updated